Bristol-Myers Squibb
BMY
#195
Rank
A$161.89 B
Marketcap
A$79.28
Share price
0.67%
Change (1 day)
16.61%
Change (1 year)

Revenue for Bristol-Myers Squibb (BMY)

Revenue in 2026 (TTM): A$72.40 Billion

According to Bristol-Myers Squibb's latest financial reports the company's current revenue (TTM ) is A$67.70 Billion. In 2025 the company made a revenue of A$71.95 Billion a decrease over the revenue in the year 2024 that were of A$77.65 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bristol-Myers Squibb from 1996 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) A$72.40 B0.63%
2025 A$71.95 B-7.34%
2024 A$77.65 B17.55%
2023 A$66.05 B-2.61%
2022 A$67.83 B6.02%
2021 A$63.98 B15.71%
2020 A$55.29 B48.08%
2019 A$37.34 B16.6%
2018 A$32.02 B20.34%
2017 A$26.61 B-1.26%
2016 A$26.95 B18.56%
2015 A$22.73 B17.16%
2014 A$19.40 B5.63%
2013 A$18.36 B8.33%
2012 A$16.95 B-18.16%
2011 A$20.71 B8.02%
2010 A$19.18 B3.2%
2009 A$18.58 B-36.33%
2008 A$29.19 B39.6%
2007 A$20.91 B-7.98%
2006 A$22.72 B-13.43%
2005 A$26.24 B15.65%
2004 A$22.69 B-19.75%
2003 A$28.28 B-12.05%
2002 A$32.16 B-14.43%
2001 A$37.58 B10.17%
2000 A$34.11 B15.71%
1999 A$29.48 B-1.28%
1998 A$29.86 B16.49%
1997 A$25.63 B35.18%
1996 A$18.96 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
A$134.56 B 98.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$79.01 B 16.70%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$88.41 B 30.59%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$85.40 B 26.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$100.89 B 49.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$51.97 B-23.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$77.45 B 14.39%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$13.87 B-79.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$91.84 B 35.65%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$84.40 B 24.66%๐Ÿ‡ฌ๐Ÿ‡ง UK